Kang Byung Woog, Kwon Oh-Kyoung, Chung Ho Young, Yu Wansik, Kim Jong Gwang
Department of Oncology/Hematology, Kyungpook National University Medical Center, Kyungpook National University School of Medicine, Kyungpook National University Cancer Research Institute, 807 Hogukno, buk-gu, Daegu 41404, Korea.
Department of Surgery, Kyungpook National University Hospital, Kyungpook National University School of Medicine, Daegu 41494, Korea.
Molecules. 2016 May 17;21(5):651. doi: 10.3390/molecules21050651.
Although rapid advances in treatment options have improved the prognosis of advanced gastric cancer (AGC), it remains a major public health problem and the second leading cause of cancer-related deaths in the world. Taxanes (paclitaxel and docetaxel) are microtubule stabilizing agents that inhibit the process of cell division, and have shown antitumor activity in the treatment of AGC as a single or combination chemotherapy. Accordingly, this review focuses on the efficacy and tolerability of taxanes in the first- or second-line chemotherapy setting for AGC.
尽管治疗方案的迅速进展改善了晚期胃癌（AGC）的预后，但它仍然是一个主要的公共卫生问题，并且是全球癌症相关死亡的第二大主要原因。紫杉烷类（紫杉醇和多西他赛）是抑制细胞分裂过程的微管稳定剂，并且已显示出作为单一疗法或联合化疗在AGC治疗中的抗肿瘤活性。因此，本综述着重于紫杉烷类在AGC一线或二线化疗中的疗效和耐受性。
